376sek
-1,6 %
Date:2025-05-30Time:18:00:00Latest report:Q4-2020List:First NorthTicker:CMH PREF
Market Cap:16 msekEnterprise Value:16 msekNet Sales:- msekEarnings:- msekEmployees:0ISIN:SE0023848619

Ratios

10-year key figure history for Chordate Medical Pref turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Chordate Medical Pref with index and moving average MA50 and MA200.

Stockprice:3,76
MA50:-
MA200:-
Price/MA200:-
RSI (14):-
Price/MA50:-

Description

Chordate Medical Holding is a medical technology company that has developed, patented and CE-marked Ozilia® Migraine, a neuromodulatory and drug-free treatment technique for chronic migraine and chronic rhinitis. The treatment has proven efficacy according to a clinical study and is marketed in selected markets in the EU and the Middle East. The company is headquartered in Kista.

Medical Equipment